CROI 2024 Program Guide

Poster Sessions

622

Acceptability of Long-Acting Cabotegravir & Rilpivirine in a Large Urban Ambulatory HIV Clinic Casey M. Luc , Blake Max, Sarah Perez, Kara Herrera, Mark Dworkin Real-World Effectiveness of Cabotegravir + Rilpivirine vs Standard of Care Oral Regimens in the US Ricky K. Hsu , Michael Sension, Jennifer S Fusco, Laurence Brunet, Quateka Cochran, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Michael B Wohlfeiler, Brooke Levis, Gregory P Fusco Predictors of Injection Visit Adherence in Those Receiving Injectable Cabotegravir/Rilpivirine Lucas Hill , Jeffrey Yin, Nimish Patel, Kari Abulhosn, Elvia Suarez, Afsana Karim, Laura Bamford Real-World Utilization of Cabotegravir + Rilpivirine in the US: Data From Trio Health Cohort Joseph J. Eron , Supriya Sarkar, Andrew J Frick, Gayathri Sridhar, Leigh Ragone, Karam Mounzer, Steven Santiago, Jean Van Wyk, Richard A Elion, Vani Vannappagari Real-World Virologic Outcomes of Cabotegravir/Rilpivirine in Patients With Elevated Body Mass Index Christina Maguire , Eric Farmer, Emily Huesgen, Kaitlyn Rueve, Marisa Brizzi, Amanda Binkley, Bernice Kear, Pallavi Chary, Helen Koenig, Peter Sung, Emily Hiserodt, Karam Mounzer, Danielle Rocha, Adrian Altieri, William R Short HIV-1 RNA Blips and Low-Level Viral Replication: SOLAR (CAB+RPV LA vs BIC/FTC/TAF) Christine Latham , Rimgaile Urbaityte, Kenneth Sutton, William Spreen, Ronald D’Amico 24-Week Viral Suppression in Patients Starting Long-Acting CAB/RPV Without HIV Viral Suppression Matt Hickey , Janet Grochowski, Francis Mayorga-Munoz, Elizabeth Imbert, John D Szumowski, Jon Oskarsson, Mary Shiels, Samantha Dilworth, Ayesha Appa, Diane Havlir, Monica Gandhi, Katerina Christopoulos Case Series Examining the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial Monica Gandhi , Lucas Hill, Janet Grochowski, Alexander Nelson, Katerina Christopoulos, Diane Havlir, Catherine A Koss, Francis Mayorga-Munoz, Jon Oskarsson, John D Szumowski, Ann Avery, Laura Bamford, Jillian Baron, William R Short, Corrilynn O Hileman Lenacapavir Efficacy in CAPELLA Patients With No Fully Active Agents in Optimized Background Regimen Onyema Ogbuagu, Winai Ratanasuwan, Anchalee Avihingsanon, Ploenchan Chetchotisakd, Andrew Wiznia, Kimberly Workowski, Chien-Ching Hung, Jason Brunetta, Benoit Trottier, Mohammed Rassool, Hui Wang, Nicolas Margot, Hadas Dvory-Sobol, Martin S Rhee, Sorana Segal-Maurer Intramuscular Injection vs Intravenous Infusion of Ibalizumab for HTE PWH: The Results of TMB-302 Kaitlin R Anstett, R Brandon Cash, Anthony Mills , Mezgebe Berhe, Edwin DeJesus

Poster Sessions • Monday

623

624

625

626

627

628

629

630

631

CROI 2024 79

New Investigator Scholarship

LB

NIS

Late-Breaking